HASCO-LEK - Key Persons
Job Titles:
- Member of the Management Board of PPF Hasco - Lek S.a
In 2013, she took up the position of Director of Foreign Trade Operations, overseeing export and distribution of over 350 medicinal products, dietary supplements and medical devices from Hasco-Lek's portfolio, including, among others, brands such as: IBUM, Mensil, DIH, Juvit, Hascovir, Ulgix, Mel. She is also responsible for managing licence purchasing and sale as well as contract and private label manufacture. Thanks to her work, the company's products are exported to 30 countries, including the UK, Germany, Belgium, Italy, Israel, Austria, Lithuania, Norway and Bulgaria. CEO Agnieszka Han is also involved in the development of other Hasco Group companies. In 2018, she was appointed the Vice President of the Management Board of PPF Hasco-Lek S.A., where she is in charge of marketing and market management.
MSc in pharmacy, graduated from the Wrocław Medical University and the University of Bologna. Started working for Hasco-Lek in 2005. Since 2006, she has been the President of the Management Board of the HASCO-LEK Foundation, which, from its very creation, has been contributing to social and educational projects and actively supporting those in need, in particular individuals with disabilities.
Job Titles:
- Member of the Management Board of PPF Hasco - Lek S.a
A graduate of the Faculty of Economics at the European University VIADRINA in Frankfurt am Oder in the field of Business Economics (BWL). He joined the Hasco Group in 2018, and since 2021 he has been the President of the Management Board of PCF Procefar, responsible for the area of finance, accounting, and controlling. Since May 2023, he has also been a Member of the Management Board of PPF Hasco-Lek S.A., where he is responsible for shaping the company's financial strategy.
Job Titles:
- Member of the Management Board of PPF Hasco - Lek S.a
Involved with the HASCO Group as Vice President of the Management Board, he is responsible for the business development of the Group. He supervises the scientific research conducted and the transfer and implementation of technologies. He is in charge of the activity of Novasome Research and Development Centre as the President of the Management Board and CEO. He is the originator of the Scientific Board, which advises the company on development and research plans.